JPWO2023012280A5 - - Google Patents

Info

Publication number
JPWO2023012280A5
JPWO2023012280A5 JP2024504780A JP2024504780A JPWO2023012280A5 JP WO2023012280 A5 JPWO2023012280 A5 JP WO2023012280A5 JP 2024504780 A JP2024504780 A JP 2024504780A JP 2024504780 A JP2024504780 A JP 2024504780A JP WO2023012280 A5 JPWO2023012280 A5 JP WO2023012280A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cms
sterile aqueous
ncfb
cba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504780A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527021A5 (https=
JP2024527021A (ja
Publication date
Priority claimed from EP21189819.2A external-priority patent/EP4129322A1/en
Application filed filed Critical
Publication of JP2024527021A publication Critical patent/JP2024527021A/ja
Publication of JP2024527021A5 publication Critical patent/JP2024527021A5/ja
Publication of JPWO2023012280A5 publication Critical patent/JPWO2023012280A5/ja
Pending legal-status Critical Current

Links

JP2024504780A 2021-08-05 2022-08-04 非嚢胞性線維症気管支拡張症の治療 Pending JP2024527021A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21189819.2A EP4129322A1 (en) 2021-08-05 2021-08-05 Treatment of non-cystic fibrosis bronchiectasis
EP21189819.2 2021-08-05
PCT/EP2022/071960 WO2023012280A1 (en) 2021-08-05 2022-08-04 Treatment of non-cystic fibrosis bronchiectasis

Publications (3)

Publication Number Publication Date
JP2024527021A JP2024527021A (ja) 2024-07-19
JP2024527021A5 JP2024527021A5 (https=) 2025-07-31
JPWO2023012280A5 true JPWO2023012280A5 (https=) 2025-07-31

Family

ID=77226670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504780A Pending JP2024527021A (ja) 2021-08-05 2022-08-04 非嚢胞性線維症気管支拡張症の治療

Country Status (8)

Country Link
US (1) US20240342239A1 (https=)
EP (2) EP4129322A1 (https=)
JP (1) JP2024527021A (https=)
CN (1) CN117794559A (https=)
AU (1) AU2022324695A1 (https=)
BR (1) BR112024001945A2 (https=)
CA (1) CA3226916A1 (https=)
WO (1) WO2023012280A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2343122B (en) 1998-10-26 2003-01-08 Medic Aid Ltd Improvements in and relating to nebulisers

Similar Documents

Publication Publication Date Title
ES2222294T3 (es) Formulacion optimizada de tobramicina para administracion en forma de aerosol.
JP2008536546A5 (https=)
BG108457A (bg) Метод и комплект за увеличаване обема на косата
US20160166505A1 (en) Methods And Compositions For Treatment Of Respiratory Tract Infections
RU2008135580A (ru) Альфа-1-антитрипсин для лечения эпизодов воспаления болезней легких
JP2015232026A (ja) 人工呼吸器関連肺炎(vap)及び人工呼吸器関連気管(vat)気管支炎の治療のためのアミカシンとホスホマイシンの組み合わせの製剤並びに方法及びシステム
ES2281021T3 (es) Formulacion liquida que contiene tobramicina.
O'Riordan Inhaled antimicrobial therapy: from cystic fibrosis to the flu
Kuhn Pharmaceutical considerations in aerosol drug delivery
JP2014526481A (ja) アルベカシンを含有する水性組成物
US10406171B2 (en) Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
JPH02196716A (ja) 薬学的溶液
JP2024531784A (ja) トブラマイシン吸入溶液を含む薬学的組立品及びその使用
CA2813750A1 (en) Method for treating cystic fibrosis with inhaled denufosol
US8636983B2 (en) Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
JPWO2023012280A5 (https=)
Balducci et al. Drug delivery strategies for pulmonary administration of antibiotics
CN107137518A (zh) 一种止喘灵雾化吸入用溶液制剂及其制备方法
WO2011142677A1 (en) Methods and compositions for the treatment of lung disorders
US20160143847A1 (en) Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
Han et al. Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis. Pharmaceutics 2023, 15, 1488
HK40121592A (en) Intranasal epinephrine formulations and methods for the treatment of disease
WO2021249578A2 (zh) 预防治疗哮喘或慢阻肺或过敏性疾病等的药物
AU2021235223A1 (en) Composition for the treatment of lesions of the respiratory system
US20210220371A1 (en) Method for smoking cessation